A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients

Clinical trial NCT00905268 · COMPLETED

Trial details

NCT number: NCT00905268
Sponsor: Santhera Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Friedreich's Ataxia

Start date: 2006-04-01
Primary completion: 2010-01-01
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.